Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
2010

Using MicroRNAs in Blood to Detect Breast Cancer

Sample size: 118 publication 10 minutes Evidence: moderate

Author Information

Author(s): Carina Roth, Brigitte Rack, Volkmar Müller, Wolfgang Janni, Klaus Pantel, Heidi Schwarzenbach

Primary Institution: Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf

Hypothesis

Circulating microRNAs can serve as biomarkers for the detection and staging of breast cancer.

Conclusion

The study found that circulating microRNAs are elevated in the blood of breast cancer patients and are associated with tumor progression.

Supporting Evidence

  • Circulating total RNA and specific microRNAs were significantly higher in breast cancer patients compared to healthy individuals.
  • MicroRNA levels correlated with tumor stage and presence of metastases.
  • The study suggests that microRNAs could be used as non-invasive biomarkers for breast cancer.

Takeaway

Doctors can look at tiny pieces of RNA in the blood to help find out if someone has breast cancer and how serious it is.

Methodology

The study measured the concentrations of specific microRNAs in the blood serum of breast cancer patients and healthy controls using a TaqMan MicroRNA Assay.

Limitations

The study's blood samples were collected post-surgery, which may affect RNA levels, and the small number of patients with circulating tumor cells limited statistical analysis.

Participant Demographics

Patients included 59 with primary breast cancer and 30 with metastatic disease, with a median age of 56 years.

Statistical Information

P-Value

0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr2766

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication